@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix prov: . @prefix obo: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasPart: . @prefix ProteinComplex: . @prefix occursIn: . @prefix hasAnnotation: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasPart: hgnc:1773, sub:_2; occursIn: obo:EFO_0001200; hasAnnotation: sub:_3; a ProteinComplex: . sub:_2 geneProductOf: hgnc:7553; a Protein: . sub:_3 dct:subject "TextLocation"; rdf:value "Abstract" . sub:assertion rdfs:label "complex(p(HGNC:MYC),g(HGNC:CDK4))" . } sub:provenance { beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds."; dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved."; dce:title "BEL Framework Small Corpus Document"; dct:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value """c-Myc was present on the CDK4 promoter to the small extent expected in nontumorigenic cells (8). ChIP with c-Myc antibodies was repeated in the MCF-7 breast cancer cell line, where c-Myc is more abundant (8), to rule out a problem of detection sensitivity. This analysis clearly demonstrated the presence of c-Myc at the CDK4 promoter."""; prov:wasQuotedFrom pubmed:12857727 . sub:_5 rdfs:comment "support@belframework.org"; rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12857727; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:16.986+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }